OJPM  Vol.4 No.4 , April 2014
Cardiometabolic Phenotype and Arterial Stiffness in HIV-Positive Black African Patients
ABSTRACT

Objective: To test the hypothesis that Human Immunodeficiency Virus (HIV) infection in Black patients is associated with increased cardiometabolic risk factors that may increase aortic stiffness assessed by pulse wave velocity (PWV). Methods: We matched 96 Cameroonian Controls to 238 (Un) treated HIV-positive patients [HIV] for age. In each participant, aortic PWV (ComplioR), blood pressures (BP), lipid profile and fasting blood glucose (FPG) were measured. Results: Waist circumference was lower in HIV than in Controls (both p < 0.001). The prevalences of impaired FPG (100-125 mg·dl-1), and of diabetes (FPG > 125 mg·dl-1) were higher in HIV than in the Controls (50% vs 27%, and 23% vs 1%, respectively; both p < 0.0001). HDL-C was lower in HIV as compared to the Control (p = 0.02). Fasting triglycerides (TG) and the atherogenic dyslipidemia ratio [log(TG)/HDL-C] were higher in HIV than in the Controls (both p < 0.05). Hypertension prevalence was high but comparable in the two groups (48% vs 44% respectively, p > 0.05). HIV patients exhibited a twice-higher prevalence of MetS (AHA/NHLBI score 33/5) than that of the Controls (41% vs 21%; p < 0.01). Similarly, severity of MetS phenotype was higher in HIV as compared to the Controls (2.14% vs 1.59%; p < 0.0001). PWV adjusted for age, mean BP and gender was faster in HIV in comparison to the controls (7.33 m/s vs 6.86 m/s, respectively; p = 0.036). Conclusions: HIV infection is associated with higher prevalence of MetS and its phenotype in Black African patients that may induce increased aortic stiffness.


Cite this paper
Lemogoum, D. , Ngatchou, W. , Borne, P. , Ndobo, V. , Leeman, M. , Yagnigni, E. , Tiogou, E. , Nga, E. , Kouanfack, C. , Bortel, L. , Degaute, J. and Hermans, M. (2014) Cardiometabolic Phenotype and Arterial Stiffness in HIV-Positive Black African Patients. Open Journal of Preventive Medicine, 4, 182-192. doi: 10.4236/ojpm.2014.44024.
References
[1]   Sabin, C.A., Worm, S.W., Weber, R., et al. (2008) Use of Nucleoside Reverse Transcriptase Inhibitors and Risk of Myocardial Infarction in HIV-Infected Patients Enrolled in the D: A: D Study: A Multi-Cohort Collaboration. Lancet, 371, 1417-1426. http://dx.doi.org/10.1016/S0140-6736(08)60423-7

[2]   Corral, I., Quereda, C., Moreno, A., et al. (2009) Cerebrovascular Ischemic Events in HIV-1-Infected Patients Receiving Highly Active Antiretroviral Therapy: Incidence and Risk Factors. Cerebrovascular Diseases, 27, 559-563.
http://dx.doi.org/10.1159/000214219

[3]   Constans, J. and Conri, C. (2006) Circulating Markers of Endothelial Function in Cardiovascular Disease. Clinica Chimica Acta, 368, 33-47. http://dx.doi.org/10.1016/j.cca.2005.12.030

[4]   Hsue, P.Y., Lo, J.C., Franklin, A., et al. (2004) Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients with HIV Infection. Circulation, 109, 1603-1608.
http://dx.doi.org/10.1161/01.CIR.0000124480.32233.8A

[5]   Lorenz, M.W., Stephan, C., Harmjanz, A., et al. (2008) Both Long-Term HIV Infection and Highly Active Antiretroviral Therapy Are Independent Risk Factors for Early Carotid Atherosclerosis. Atherosclerosis, 196, 720-726.
http://dx.doi.org/10.1016/j.atherosclerosis.2006.12.022

[6]   Glazier, J.J., Spears, J.R. and Murphy, M.C. (2006) Interventional Approach to Recurrent Myocardial Infarction in HIV-1 Infection. Journal of Interventional Cardiology, 19, 93-98. http://dx.doi.org/10.1111/j.1540-8183.2006.00111.x

[7]   Fourie, C., van Rooyen, J., Pieters, M., Conradie, K., Hoekstra, T. and Schutte, A. (2011) Is HIV-1 Infection Associated with Endothelial Dysfunction in a Population of African Ancestry in South Africa? Cardiovascular Journal of Africa, 22, 134-140. http://dx.doi.org/10.5830/CVJA-2010-056

[8]   Fisher, S.D., Miller, T.L. and Lipshultz, S.E. (2006) Impact of HIV and Highly Active Antiretroviral Therapy on Leukocyte Adhesion Molecules, Arterial Inflammation, Dyslipidemia, and Atherosclerosis. Atherosclerosis, 185, 1-11.
http://dx.doi.org/10.1016/j.atherosclerosis.2005.09.025

[9]   Schillaci, G., De Socio, G.V., Pucci, G., et al. (2008) Aortic Stiffness in Untreated Adult Patients with Human Immunodeficiency Virus Infection. Hypertension, 52, 308-313.
http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.114660

[10]   Aberg, J.A. (2009) Cardiovascular Complications in HIV Management: Past, Present, and Future. Journal of Acquired Immune Deficiency Syndromes, 50, 54-64. http://dx.doi.org/10.1097/QAI.0b013e31818ceaa4

[11]   Feitas, P., Carvalho, D., Souto, S., et al. (2011) Impact of Lipodystrophy on the Prevalence and Components of Metabolic Syndrome in HIV-Infected Patients. BMC Infectious Diseases, 11, 246.
http://dx.doi.org/10.1186/1471-2334-11-246

[12]   Lakka, H.M., Laaksonen, D.E., Lakka, T.A., et al. (2002) The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-Aged Men. Journal of the American Medical Association, 288, 2709-2716.
http://dx.doi.org/10.1001/jama.288.21.2709

[13]   Hansen, T.W., Staessen, J.A., Torp-Pedersen, C., et al. (2006) Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population. Circulation, 113, 664-670.
http://dx.doi.org/10.1161/CIRCULATIONAHA.105.579342

[14]   Lekakis, J., Ikonomidis, I., Palios, J., et al. (2009) Association of Highly Active Antiretroviral Therapy with Increased Arterial Stiffness in Patients Infected with Human Immunodeficiency Virus. American Journal of Hypertension, 22, 828-834. http://dx.doi.org/10.1038/ajh.2009.90

[15]   Joint United Nations Programme on HIV/AIDS (UNAIDS) (2008) Report on the Global HIV/AIDS Epidemic. Geneva. http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp

[16]   Mancia, G., De Backer, G., Dominiczak, A., et al. (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 25, 1105-1187.
http://dx.doi.org/10.1097/HJH.0b013e3281fc975a

[17]   Grundy, S.M., Cleeman, J.I., Daniels, S.R., et al. (2005) Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735-2752. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.169404

[18]   Hermans, M.P., Ahn, S.A. and Rousseau, M.F. (2010) log (TG)/HDL-C Is Related to Both Residual Cardiometabolic Risk and β-Cell Function Loss In type 2 Diabetes Males. Cardiovascular Diabetology, 9, 88.
http://dx.doi.org/10.1186/1475-2840-9-88

[19]   Asmar, R., Benetos, A., Topouchian, J., et al. (1995) Assessment of Arterial Distensibility by Automatic Pulse Wave Velocity Measurement. Validation and Clinical Application Studies. Hypertension, 26, 485-490.
http://dx.doi.org/10.1161/01.HYP.26.3.485

[20]   Lemogoum, D., Van Bortel, L., Najem, B., et al. (2004) Arterial Stiffness and Wave Reflections in Patients with Sickle Cell Disease. Hypertension, 44, 924-929. http://dx.doi.org/10.1161/01.HYP.0000148506.73622.ba

[21]   Twagirumukiza, M., De Bacquer, D., Kips, J., de Backer, G., Vander Stichele, R. and Van Bortel, L. (2011) Current and Projected Prevalence of Arterial Hypertension in Sub-Saharan Africa by Sex, Age and Habitat: An Estimate from Population Studies. Journal of Hypertension, 29, 1243-1252. http://dx.doi.org/10.1097/HJH.0b013e328346995d

[22]   Palacios, R., Santos, J., García, A., Castells, E., González, M., Ruiz, J. and Márquez, M. (2006) Impact of Highly Active Antiretroviral Therapy on Blood Pressure in HIV-Infected Patients. A Prospective Study in a Cohort of Naive Patients. HIV Medicine, 7, 10-15. http://dx.doi.org/10.1111/j.1468-1293.2005.00333.x

[23]   Bloomfield, G.S., Hogan, J.W., Keter, A., Sang, E., Carter, E.J., Velazquez, E.J. and Kimaiyo, S. (2011) Hypertension and Obesity as Cardiovascular Risk Factors among HIV Seropositive Patients in Western Kenya. PloS ONE, 6, Article ID: e22288. http://dx.doi.org/10.1371/journal.pone.0022288

[24]   He, F.J. and MacGregor, G.A. (2009) A Comprehensive Review on Salt and Health and Current Experience of Worldwide Salt Reduction Programmes. Journal of Human Hypertension, 23, 363-384. http://dx.doi.org/10.1038/jhh.2008.144

[25]   He, F.J., Marciniak, M., Visagie, E., Markandu, N.D., Anand, V., Dalton, R.N. and MacGregor, G.A. (2009) Effect of Modest Salt Reduction on Blood Pressure, Urinary Albumin, and Pulse Wave Velocity in White, Black, and Asian Mild Hypertensives. Hypertension, 54, 482-488. http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.133223

[26]   Yoshida, M., Mita, T., Yamamoto, R., Shimizu, T., Ikeda, F., Ohmura, C., Kanazawa, A., Hirose, T., Kawamori, R. and Watada, H. (2012) The Combination of Framingham Risk Score and Carotid Intima-Media Thickness Improves the Prediction of Cardiovascular Events in Patients with Type 2 Diabetes. Diabetes Care, 35, 178-180.
http://dx.doi.org/10.2337/dc11-1333

[27]   Brown, T.T., Cole, S.R., Li, X., Kingsley, L.A., Palella, F.J., Riddler, S.A., Visscher, B.R., Margolick, J.B. and Dobs, A.S. (2005) Antiretroviral Therapy and the Prevalence and Incidence of Diabetes Mellitus in the Multicenter AIDS Cohort Study. JAMA Internal Medicine, 165, 1179-1184. http://dx.doi.org/10.1001/archinte.165.10.1179

[28]   Capeau, J., Bouteloup, V., Katlama, C., et al. (2012) Ten-Year Diabetes Incidence in 1046 HIV-Infected Patients Started on a Combination Antiretroviral Treatment: The ANRS CO8 APROCO-COPILOTE Cohort. AIDS, 26, 303-314.
http://dx.doi.org/10.1097/QAD.0b013e32834e8776

[29]   Mineo, C., Deguchi, H., Griffin, J.H. and Shaul, P.W. (2006) Endothelial and Antithrombotic Actions of HDL. Circulation Research, 98, 1352-1364. http://dx.doi.org/10.1161/01.RES.0000225982.01988.93

[30]   Patel, S., Puranik, R., Nakhla, S., Lundman, P., Stocker, R., Wang, X.S., Lambert, G., Rye, K.A., Barter, P.J., Nicholls, S.J. and Celermajer, D.S. (2009) Acute Hypertriglyceridaemia in Humans Increases the Triglyceride Content and Decreases the Anti-Inflammatory Capacity of High Density Lipoproteins. Atherosclerosis, 204, 424-428.
http://dx.doi.org/10.1016/j.atherosclerosis.2008.07.047

[31]   Cziraky, M.J., Watson, K.E. and Talbert, R.L. (2008) Targeting Low HDL-Cholesterol to Decrease Residual Cardiovascular Risk in the Managed Care Setting. Journal of Managed Care Pharmacy, 14, S3-S28.

[32]   Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.R. and Groop, L. (2001) Cardiovascular Morbidity and Mortality Associated with the Metabolic Syndrome. Diabetes Care, 24, 683-689.
http://dx.doi.org/10.2337/diacare.24.4.683

[33]   Greenwald, S., Carter, A. and Berry, C. (1990) Effect of Age on the in Vitro Reflection Coefficient of the Aortoiliac Bifurcation in Humans. Circulation, 82, 114-123. http://dx.doi.org/10.1161/01.CIR.82.1.114

[34]   Avolio, A.P., Deng, F.Q., Li, W.Q., Luo, Y.F., Huang, Z.D., Xing, L.F. and O’Rourke, M.F. (1985) Effects of Aging on Arterial Distensibility in Populations with High and Low Prevalence of Hypertension: Comparison between Urban and Rural Communities in China. Circulation, 71, 202-210. http://dx.doi.org/10.1161/01.CIR.71.2.202

[35]   van Vonderen, M.G., Smulders, Y.M., Stehouwer, C.D., et al. (2009) Carotid Intima-Media Thickness and Arterial Stiffness in HIV Infected Patients: The Role of HIV, Antiretroviral Therapy, and Lipodystrophy. Journal of Acquired Immune Deficiency Syndromes, 50, 153-161. http://dx.doi.org/10.1097/QAI.0b013e31819367cd

[36]   Zieman, S.J., Melenovsky, V. and Kass, D.A. (2005) Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 932-943.
http://dx.doi.org/10.1161/01.ATV.0000160548.78317.29

[37]   McEniery, C.M. and Wilkinson, I.B. (2005) Large Artery Stiffness and Inflammation. Journal of Human Hypertension, 19, 507-509. http://dx.doi.org/10.1038/sj.jhh.1001814

[38]   Hingorani, A.D., Cross, J., Kharbanda, R.K., et al. (2000) Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans. Circulation, 102, 994-999. http://dx.doi.org/10.1161/01.CIR.102.9.994

 
 
Top